| Summary of earning per share basic and diluted reconciliation |
The following table includes the calculation of basic and diluted net income/(loss) per share:
|
|
|
|
|
|
|
|
|
| |
|
Six Months Ended June 30, |
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
(in thousands except per share |
|
Loss from continuing operations |
|
$ |
(203,119 |
) |
|
$ |
(23,683 |
) |
(Loss) / gain from discontinued operation |
|
|
(1,022 |
) |
|
|
28,960 |
|
| |
|
|
|
|
|
|
|
|
Net (loss) / income available to common stockholders |
|
$ |
(204,141 |
) |
|
$ |
5,277 |
|
| |
|
|
|
|
|
|
|
|
Basic and diluted net loss per share - continuing operations |
|
$ |
(0.69 |
) |
|
$ |
(0.31 |
) |
Basic and diluted net income per share - discontinued operations |
|
|
— |
|
|
|
0.37 |
|
| |
|
|
|
|
|
|
|
|
Basic and diluted net (loss) / income per share |
|
$ |
(0.69 |
) |
|
$ |
0.06 |
|
| |
|
|
|
|
|
|
|
|
Shares used in the computation of basic and diluted net (loss)/income per share |
|
|
294,224 |
|
|
|
77,371 |
|
|
The following table includes the calculation of basic and diluted net income/(loss) per share:
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
| |
|
(in thousands except per
share information) |
|
Loss from continuing operations |
|
$ |
(47,720 |
) |
|
$ |
(59,985 |
) |
Income/(loss) from discontinued operations |
|
|
28,185 |
|
|
|
(6,160 |
) |
| |
|
|
|
|
|
|
|
|
Net loss available to common stockholders |
|
$ |
(19,535 |
) |
|
$ |
(66,145 |
) |
| |
|
|
|
|
|
|
|
|
Basic and diluted net loss per share - continuing operations |
|
$ |
(0.55 |
) |
|
$ |
(2.23 |
) |
Basic and diluted net income/(loss) per share - discontinued operations |
|
|
0.32 |
|
|
|
(0.23 |
) |
| |
|
|
|
|
|
|
|
|
Basic and diluted net loss per share - total |
|
$ |
(0.23 |
) |
|
$ |
(2.46 |
) |
| |
|
|
|
|
|
|
|
|
Shares used in computation of basic and diluted net income/(loss) per share |
|
|
87,479 |
|
|
|
26,942 |
|
|
| Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following potentially dilutive securities were not included in the calculation of weighted average common shares outstanding, as their effect would have been anti-dilutive during the six months ended June 30, 2021 and 2020:
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
Series A redeemable convertible preferred stock |
|
|
8,652 |
|
|
|
8,652 |
|
Series B and B-1 redeemable convertible preferred stock |
|
|
28,495 |
|
|
|
28,495 |
|
Series C redeemable convertible preferred stock |
|
|
41,908 |
|
|
|
41,908 |
|
| |
|
|
6,361 |
|
|
|
13,951 |
|
| |
|
|
98,100 |
|
|
|
— |
|
| |
|
|
122,986 |
|
|
|
134,996 |
|
2021 Convertible Bridge Notes as converted in common stock |
|
|
86,290 |
|
|
|
— |
|
Class A Common Stock warrants (as exercised for Class A Common Stock) treated as liability |
|
|
42,945 |
|
|
|
— |
|
Class A Common Stock warrants (as exercised for Class A Common Stock) treated as liability in connection with the Rights Offering |
|
|
565 |
|
|
|
— |
|
Common stock issuable for consent fees |
|
|
3,456 |
|
|
|
— |
|
Series B preferred stock warrants |
|
|
1,055 |
|
|
|
1,055 |
|
Series C preferred stock warrants |
|
|
203 |
|
|
|
203 |
|
| |
|
|
28,980 |
|
|
|
40,916 |
|
|
The following potentially dilutive securities were not included in the calculation of weighted average common shares outstanding, as their effect would have been anti-dilutive for the years ended December 31:
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
Series A redeemable convertible preferred stock |
|
|
8,652 |
|
|
|
8,652 |
|
Series B and B-1 redeemable convertible preferred stock |
|
|
28,495 |
|
|
|
28,495 |
|
Series C redeemable convertible preferred stock |
|
|
41,908 |
|
|
|
39,824 |
|
| |
|
|
9,767 |
|
|
|
— |
|
| |
|
|
134,996 |
|
|
|
126,662 |
|
Series B preferred stock warrants |
|
|
1,055 |
|
|
|
1,055 |
|
Series C preferred stock warrants |
|
|
203 |
|
|
|
8,541 |
|
| |
|
|
38,258 |
|
|
|
42,276 |
|
|